Adaptimmune Therapeutics News, Adaptimmune Therapeutics Quote, ADAP Quote

Adaptimmune Therapeutics (NQ:ADAP) Delayed: 0.98 +0.08 (8.89%)

Prev. Close

$0.90

Open

$0.92

52 Wk High

$12.85

52 Wk Low

$3.76

Day High

$1.10

Day Low

$0.92

P/E

N/A

EPS

$0.00

Volume

1,482,350

Friends, Peers and Foes (?): ALVR, TSVT, BLBD, NVS TCRR (more...)

Apr 12, 2024 08:06 AM Form 8-K Adaptimmune Therapeutics For: Apr 10
Apr 12, 2024 08:02 AM Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
Apr 11, 2024 08:01 AM Form DEF 14A Adaptimmune Therapeutics For: May 14
Apr 2, 2024 08:39 PM Form SC 13D/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
Apr 1, 2024 08:02 AM Form PRE 14A Adaptimmune Therapeutics For: May 14
Mar 27, 2024 07:32 PM Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
Mar 26, 2024 12:00 PM Form 3 Adaptimmune Therapeutics For: Mar 08 Filed by: EcoR1 Capital, LLC
Mar 26, 2024 11:59 AM Form SC 13G/A Adaptimmune Therapeutics Filed by: EcoR1 Capital, LLC
Mar 18, 2024 05:00 PM Form 4 Adaptimmune Therapeutics For: Mar 18 Filed by: Piccina Cintia
Mar 7, 2024 12:24 PM Jones Trading Upgrades Adaptimmune Therapeutics plc (ADAP) to Buy on improving biotech sector

Entities mentioned with ADAP